Document Detail


Neurometabolite abnormalities in simian immunodeficiency virus-infected macaques with chronic morphine administration.
MedLine Citation:
PMID:  20938808     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Opiate abuse increases the risk for human immunodeficiency virus (HIV) infection, while both opiates and HIV may impact the immune and nervous systems. To model potential interactions between opiate drugs and HIV on the brain, neurometabolite levels were evaluated in simian immunodeficiency virus (SIV)-infected macaques with or without chronic morphine administration. Over the course of the study, 58% of these SIV-infected animals progressed to acquired immune deficiency syndrome (AIDS). Brain extracts from four brain regions were evaluated with proton magnetic resonance spectroscopy. Animals with AIDS had lower N-acetyl-aspartate in all four brain regions (p ≤ 0.05) as well as lower frontal gray matter total creatine (p = 0.03), lower frontal white matter (p = 0.003) and caudate (p = 0.002) glutamate, and higher frontal white matter myo-inositol (p = 0.05) than the healthier non-AIDS macaques. Morphine-dependent animals had higher levels of myo-inositol in the putamen (p = 0.003), especially those with AIDS. In the animals with AIDS, those with morphine dependence had higher total creatine in the frontal white matter (p = 0.04) than those treated with saline, which in turn had lower creatine than saline-injected animals without AIDS (p = 0.04), leading to an interaction between the effects of morphine and AIDS on total creatine in this brain region (ANOVA p = 0.02). The majority of these brain metabolites correlated with viral counts indicating more severe metabolite abnormalities in animals with higher viral loads or set points. Collectively, these findings suggest that chronic morphine may protect against the neurotoxic effect of AIDS and reinforce the importance of maintaining a low viral load in AIDS.
Authors:
Christine C Cloak; Linda Chang; Shawn P O'Neil; Thomas M Ernst; Daniel C Anderson; Robert M Donahoe
Related Documents :
9834928 - Role of cytokines in aids wasting.
2118978 - The possible role of fungal infections in aids.
11121048 - Genetic restriction of hiv-1 pathogenesis to aids by promoter alleles of il10.
1821318 - Clinical manifestations and treatment of hiv related non-hodgkin lymphoma.
16647668 - Common problems of urination in nonpregnant women: causes, current management, and prev...
19156678 - A latent class factor approach to identifying subtypes of juvenile diversion youths bas...
Publication Detail:
Type:  Journal Article     Date:  2010-10-12
Journal Detail:
Title:  Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology     Volume:  6     ISSN:  1557-1904     ISO Abbreviation:  J Neuroimmune Pharmacol     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-07-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256586     Medline TA:  J Neuroimmune Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  371-80     Citation Subset:  IM    
Affiliation:
Department of Medicine, Neuroscience and MRI Research, University of Hawaii, 1356 Lusitana St #713, Honolulu, HI, 96813, USA, cloak@hawaii.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Letter concerning "Enzyme replacement therapy in a patient with Fabry disease and the development of...
Next Document:  M. tuberculosis H37Rv Infection of Chinese Rhesus Macaques.